Возраст домена | n/a |
Дата окончания | n/a |
PR | 3 |
ИКС | |
Страниц в Google | 132 |
Страниц в Яндексе | 14 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 6993344 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Canadian Health Policy
n/a
n/a
UTF-8
39.94 КБ
788
6 219 симв.
5 268 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
2 | 7 |
0 | 19436 | ![]() | |
![]() ![]() |
1 | 5 |
0 | 11661687 | ![]() |
|
![]() ![]() |
1 | 5 |
0 | 7275734 | ![]() |
|
![]() ![]() |
1 | 7 |
0 | 238864 | ![]() | |
![]() |
1 | 5 |
0 | 1446304 | ![]() |
|
![]() ![]() |
1 | 8 |
0 | 213750 | ![]() | |
![]() |
1 | 3 |
0 | 4296019 | ![]() | |
![]() ![]() |
1 | 5 |
10 | 720589 | ![]() | |
![]() |
1 | 4 |
0 | 1904698 | ![]() | |
![]() |
1 | 5 |
10 | 732013 | ![]() | |
Еще 8 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 30 Августа 2014 ) | |
Количество ссылок на сайт | 7 |
Количество доменов, которые ссылаются на сайт | 6 |
Количество найденных анкоров | 6 |
Исходящие (внешние) ссылки домена | 221 |
Количество доменов, на которые ссылается сайт | 12 |
Количество исходящих анкоров | 13 |
Внешние ссылки главной страницы ( 7 ) | |
twitter.com/CHPI1 | Tweets by @CHPI1 |
youtube.com/channel/UCimW9F5RCB2NPqnxv2reCeA | View our YouTube channel |
business.financialpost.com/news/election-2019/voters-beware-... | Pharmacare is unnecessary, bad for privately insured Canadians and costly for taxpayers. |
nationalpost.com/opinion/opinion-civil-servants-get-the-roll... | Civil servants get the Rolls Royce of pharmacare while party leaders can't even muster a decent plan |
business.financialpost.com/opinion/new-rules-will-keep-the-b... | New rules will keep the best medications from desperate Canadians |
validator.w3.org/check?uri=referer | Valid XHTML |
globalgraphicswebdesign.com/ | Globalgraphics Web Design |
Внутренние ссылки главной страницы ( 63 ) | |
# | × |
/advert.php?id=1 | <img> |
/redeem-code.html | Group Access |
/about-chpi.html | About CHPI |
/pages/article-submissions.html | Article Submissions |
/pages/people.html | People |
/pages/programs.html | Programs |
/research.html | More |
/chp-blogazine.html | CHP blogazine |
/opinions.html | Opinions |
/news.html | News |
/contact.html | Contact Us |
canadianhealthpolicy.com/products/potential-impact-of-u-s--d... | Potential impact of U.S. demand on the Canadian supply of 46 prescription drugs. » |
canadianhealthpolicy.com/products/coverage-of-new-medicines-... | Coverage of new medicines in Federal-Provincial public drug plans 2009-2018 » |
canadianhealthpolicy.com/products/coverage-of-new-medicines-... | Coverage of new medicines in private versus public drug plans in Canada 2009-2018. » |
canadianhealthpolicy.com/products/patented-drug-prices-and-c... | Patented drug prices and clinical trials in 31 OECD countries 2017: implications for Canada’s PMPRB. » |
canadianhealthpolicy.com/products/medical-resources-and-spen... | Medical resources and spending across provincial healthcare systems in Canada. » |
canadianhealthpolicy.com/products/hta-and-public-coverage-of... | HTA and public coverage of new mental health drugs in Quebec and Canada. » |
canadianhealthpolicy.com/products/medical-resources-in-canad... | Medical Resources in Canada and OECD countries. » |
canadianhealthpolicy.com/products/evidence-that-innovative-m... | Evidence that innovative medicines improve health and economic outcomes. » |
canadianhealthpolicy.com/products/close-the-gaps--patient-be... | Close the Gaps: Patient Benefits and Taxpayer Costs of 3 Pharmacare Options. » |
canadianhealthpolicy.com/products/pan-canadian-pharmaceutica... | Pan-Canadian Pharmaceutical Alliance negotiations 2014-2018. » |
canadianhealthpolicy.com/products/facts-about-the-cost-of-pa... | Facts about the cost of patented drugs in Canada: 2018 Edition. » |
canadianhealthpolicy.com/blog/video--national-pharmacare-fac... | VIDEO - National Pharmacare Facts. » |
canadianhealthpolicy.com/products/out-of-pocket-prescription... | Out-of-pocket prescription drug costs: What are the implications for National Pharmacare? » |
canadianhealthpolicy.com/products/new-patented-medicine-regu... | New Patented Medicine Regulations in Canada: Case Study of a Manufacturer’s Decision-Making » |
canadianhealthpolicy.com/products/taxpayer-cost-of-national-... | How much will National Pharmacare cost taxpayers? » |
canadianhealthpolicy.com/products/medical-devices-spending-i... | Is Canada under-investing in the use of medical devices? » |
canadianhealthpolicy.com/products/prescription-drug-plan-cov... | Who needs pharmacare? All Canadians are covered under existing private and public drug plans. » |
canadianhealthpolicy.com/products/comparing-expert-represent... | Expertise gaps on Canada’s HTA advisory committees » |
canadianhealthpolicy.com/products/consequences-of-over-regul... | Consequences of over-regulating the prices of new drugs in Canada » |
canadianhealthpolicy.com/products/costs-without-benefits-for... | Costs without benefits for patients? Non-medical spending in Canada’s public health system » |
canadianhealthpolicy.com/products/does-canada-need-a-patente... | Does Canada need a Patented Medicine Prices Review Board? » |
canadianhealthpolicy.com/products/the-fiscal-burden-of-provi... | The fiscal burden of provincial government health spending across Canada » |
canadianhealthpolicy.com/products/societal-cost-savings-from... | Abuse deterrent formulations for all prescription opioids could save $billions in societal costs » |
canadianhealthpolicy.com/products/hospital-spending-across-c... | Hospital spending compared across Canada’s Provinces » |
canadianhealthpolicy.com/products/hta-decisions-and-access-t... | HTA and delays to accessing mental health drugs in Canada » |
canadianhealthpolicy.com/products/fewer-treatment-options-fo... | Fewer treatment options for patients if Canada adopts New Zealand's prescription drug policies » |
canadianhealthpolicy.com/products/governments-could-save--5-... | Governments could save $5 billion annually by allowing modest user charges for physician services » |
canadianhealthpolicy.com/products/how-long-do-new-patented-m... | How long do new patented medicines have market exclusivity in Canada’s public drug plans? » |
canadianhealthpolicy.com/products/cost-of-physicians-across-... | What is the cost of physicians across Canada by province? » |
canadianhealthpolicy.com/products/economic-cost-of-delayed-a... | Economic cost of lost health gains from delayed access to 14 new cancer drugs. » |
canadianhealthpolicy.com/products/economic-value-of-the-util... | Capturing value for patients: HTA and the utility-expansion of new cancer drugs. » |
/advert.php?id=3 | <img> |
/products/new-drug-submissions-in-the-united-states-and-cana... | New drug submissions in the United States and Canada 2014-2019: trends and policy implications. |
/products/potential-impact-of-u-s--demand-on-the-canadian-su... | Potential impact of U.S. demand on the Canadian supply of 46 prescription drugs. |
/products/new-pathways-for-u-s--importation-threaten-canadia... | New pathways for U.S. importation threaten Canadian prescription drug supply. |
/products/preventive-care-of-the-future--economic-analysis-o... | Preventive care of the future? Economic analysis of cardiovascular risk management. |
/products/the-costs-of-immunoglobulin-treatment-in-hospital-... | The costs of Immunoglobulin treatment in hospital and in the home in Quebec |
/products/coverage-of-new-medicines-in-federal-provincial-pu... | Coverage of new medicines in Federal-Provincial public drug plans in Canada 2009-2018 |
/products/coverage-of-new-medicines-in-private-versus-public... | Coverage of new medicines in private versus public drug plans in Canada 2009-2018 |
/products/clinical-duty-to-recontact-in-genetic-testing--ins... | Clinical Duty to Recontact in Genetic Testing: Insights from the Safety-Related Duty to Recall. |
/products/patented-drug-prices-and-clinical-trials-in-31-oec... | Patented drug prices and clinical trials in 31 OECD countries 2017: implications for Canada’s PMPRB. |
/advert.php?id=2 | <img> |
/blog/gaps-in-coverage-for-take-home-cancer-drugs-in-canada-... | Gaps in coverage for take-home cancer drugs in Canada |
/news/canada-lagging-behind-international-counterparts-in-pa... | Canada lagging behind international counterparts in patient safety: CIHI report |
/news/emergency-department-wait-times-on-the-rise-in-canada-... | Emergency department wait times on the rise in Canada: CIHI data |
/news/what-the-premiers-think-about-a-national-pharmacare-pl... | What the premiers think about a national pharmacare plan |
/disclaimer.html | Disclaimer |
/privacy-policy.html | Privacy Policy |
/terms.html | Terms of Use |
/sitemap.xml | XML Sitemap |
/login.html | Forgot your password? |
Domain Name: CANADIANHEALTHPOLICY.COM
Registrar URL: http://www.godaddy.com
Registrant Name: Brett Skinner
Registrant Organization:
Name Server: NS1.TSOHOST.CO.UK
Name Server: NS2.TSOHOST.CO.UK
For complete domain details go to:
http://who.godaddy.com/whoischeck.aspx?domain=CANADIANHEALTHPOLICY.COM
Канада - Монреаль - 173.231.105.76
Fibrenoire
Fibrenoire
HTTP/1.1 200 OK
Date: Wed, 04 Dec 2019 22:40:12 GMT
Server: Apache
Expires: Thu, 19 Nov 1981 08:52:00 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Set-Cookie: PHPSESSID=982fda16eaec9cb47f65ed7dc2455db9; expires=Wed, 04-Dec-2019 23:40:12 GMT; Max-Age=3600; path=/
Content-Type: text/html; charset=UTF-8
X-Cache: MISS from lin-10-170-0-158.gridhost.co.uk
X-Cache-Lookup: HIT from lin-10-170-0-158.gridhost.co.uk:3128
Transfer-Encoding: chunked
Connection: close
Set-Cookie: DYNSRV=lin-10-170-0-158; path=/
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"